Literature DB >> 26900279

Use of Non-selective Beta-blockers in Decompensated Cirrhosis: Controversy Continues.

.   

Abstract

Entities:  

Year:  2015        PMID： 26900279      PMCID： PMC4723705          DOI： 10.1016/j.jceh.2015.11.003

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


× No keyword cloud information.
  7 in total

1.  Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2015-06-03       Impact factor: 25.083

2.  Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.

Authors:  Mattias Mandorfer; Simona Bota; Philipp Schwabl; Theresa Bucsics; Nikolaus Pfisterer; Matthias Kruzik; Michael Hagmann; Alexander Blacky; Arnulf Ferlitsch; Wolfgang Sieghart; Michael Trauner; Markus Peck-Radosavljevic; Thomas Reiberger
Journal:  Gastroenterology       Date:  2014-03-12       Impact factor: 22.682

3.  Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure.

Authors:  Rajeshwar P Mookerjee; Marco Pavesi; Karen Louise Thomsen; Gautam Mehta; Jane Macnaughtan; Flemming Bendtsen; Minneke Coenraad; Jan Sperl; Pere Gines; Richard Moreau; Vicente Arroyo; Rajiv Jalan
Journal:  J Hepatol       Date:  2015-10-28       Impact factor: 25.083

4.  Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites.

Authors:  Thomas Sersté; Christian Melot; Claire Francoz; François Durand; Pierre-Emmanuel Rautou; Dominique Valla; Richard Moreau; Didier Lebrec
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

5.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

Authors:  Richard Moreau; Rajiv Jalan; Pere Gines; Marco Pavesi; Paolo Angeli; Juan Cordoba; Francois Durand; Thierry Gustot; Faouzi Saliba; Marco Domenicali; Alexander Gerbes; Julia Wendon; Carlo Alessandria; Wim Laleman; Stefan Zeuzem; Jonel Trebicka; Mauro Bernardi; Vicente Arroyo
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

6.  Non-selective β-blockers are associated with improved survival in patients with ascites listed for liver transplantation.

Authors:  Joanna A Leithead; Neil Rajoriya; Nadeem Tehami; James Hodson; Bridget K Gunson; Dhiraj Tripathi; James W Ferguson
Journal:  Gut       Date:  2014-10-03       Impact factor: 23.059

7.  Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study.

Authors:  D Lebrec; T Poynard; P Hillon; J P Benhamou
Journal:  N Engl J Med       Date:  1981-12-03       Impact factor: 91.245
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.